Stem cell-derived dopaminergic cell transplantation shows encouraging results for Parkinson's disease
The International Society for Stem Cell Research (ISSCR) today announced the presentation of new clinical data from the STEM-PD Phase I/II clinical trial at the ISSCR 2026 Annual Meeting.